The detailed information for PTAB case with proceeding number IPR2021-00880 filed by Mylan Pharmaceuticals Inc. et al. against Regeneron Pharmaceuticals, Inc. on May 5, 2021. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2021-00880
Filing Date
May 5, 2021
Petitioner
Mylan Pharmaceuticals Inc. et al.
Respondent
Regeneron Pharmaceuticals, Inc.
Status
Final Written Decision
Respondent Application Number
14972560
Respondent Tech Center
1600
Respondent Patent Number
9669069
Institution Decision Date
Nov 10, 2021
Termination Date
Nov 9, 2022

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Other: Fed Circuit mandate

Jul 19, 2024PAPERBOARD

Patent Owner's Notice of Appeal

Jan 10, 2023PAPERPATENT OWNER

Petitioner's Amended Mandatory Notices

Dec 29, 2022PAPERPETITIONER

Ex. 3002

Nov 9, 2022EXHIBITBOARD

Final Written Decision: original

Nov 9, 2022PAPERBOARD

Other: Hearing transcript

Oct 26, 2022PAPERBOARD

Ex. 2131 - Supplemental Declaration of Doris Weber

Oct 14, 2022EXHIBITPATENT OWNER

Petitioner's Amended Mandatory Notices

Sep 29, 2022PAPERPETITIONER

Petitioner's Amended Mandatory Notices

Aug 23, 2022PAPERPETITIONER

Petitioner's Updated Exhibit List

Aug 9, 2022PAPERPETITIONER

Petitioner's Corrected Demonstratives for Oral Argument

Aug 9, 2022EXHIBITPETITIONER

Petitioner's Updated Exhibit List

Aug 5, 2022PAPERPETITIONER

Petitioner's Demonstratives for Oral Argument (-880)

Aug 5, 2022EXHIBITPETITIONER

Patent Owner's Demonstratives for Oral Argument

Aug 5, 2022EXHIBITPATENT OWNER

Patent Owner's Updated Exhibit List

Aug 5, 2022PAPERPATENT OWNER

Patent Owner's Reply on Motion to Exclude Evidence

Aug 2, 2022PAPERPATENT OWNER

Petitioner's Reply to PO's Opposition to Petitioner's Motion to Exclude Evidence

Aug 2, 2022PAPERPETITIONER

Petitioner's Updated Exhibit List

Aug 2, 2022PAPERPETITIONER

Ex. 1135 - Weber Tr.

Aug 2, 2022EXHIBITPETITIONER

Petitioner's Opposition to Patent Owner's Motion to Exclude

Jul 27, 2022PAPERPETITIONER

Patent Owner's Opposition to Petitioner's Motion to Exclude Evidence

Jul 27, 2022PAPERPATENT OWNER

Petitioner's Motion to Seal

Jul 20, 2022PAPERPETITIONER

Petitioner's Motion to Exclude Evidence CONFIDENTIAL

Jul 20, 2022PAPERPETITIONER

Petitioner's Motion to Exclude Evidence REDACTED

Jul 20, 2022PAPERPETITIONER

Patent Owner's Motion to Exclude

Jul 20, 2022PAPERPATENT OWNER

Petitioner's Amended Mandatory Notices

Jul 18, 2022PAPERPETITIONER

Order: Granting Requests for Oral Hearing

Jul 15, 2022PAPERBOARD

ORDER Granting Patent Owner's Unopposed Motions for Entry of Default Protective Order and to Seal and Petitioner's Motion to Seal

Jul 13, 2022PAPERBOARD

Petitioner's Request for Oral Argument

Jul 8, 2022PAPERPETITIONER

Patent Owner's Request for Oral Argument

Jul 8, 2022PAPERPATENT OWNER

Patent Owner's Sur-Reply

Jul 6, 2022PAPERPATENT OWNER

Thomas Albini Deposition Transcript

Jul 6, 2022EXHIBITPATENT OWNER

Mary Gerritsen Deposition Transcript

Jul 6, 2022EXHIBITPATENT OWNER

Order: Granting Petitioners Unopposed Motions for Admission pro hac vice of Robert Cerwinski, Brigid Morris, and Aviv Zalcenstein

Jun 27, 2022PAPERBOARD

Patent Owner's Notice of Deposition of Dr. Thomas A. Albini

Jun 21, 2022PAPERPATENT OWNER

PETITIONER CELLTRION, INC. UNOPPOSED MOTION FOR PRO HAC VICE ADMISSION OF ROBERT CERWINSKI UNDER 37 C.F.R. § 42.10c

Jun 14, 2022PAPERPETITIONER

PETITIONER CELLTRION, INC. UNOPPOSED MOTION FOR PRO HAC VICE ADMISSION OF BRIGID MORRIS UNDER 37 C.F.R. § 42.10(c)

Jun 14, 2022PAPERPETITIONER

EXPUNGED

Jun 14, 2022PAPERPETITIONER

PETITIONER CELLTRION, INC. UNOPPOSED MOTION FOR PRO HAC VICE ADMISSION OF AVIV ZALCENSTEIN UNDER 37 C.F.R. § 42.10(c)

Jun 14, 2022PAPERPETITIONER

Patent Owner's Second Set of Objections to Petitioner's Exhibits

Jun 6, 2022PAPERPATENT OWNER

Patent Owner's Corrected Second Set of Objections to Petitioner's Exhibits

Jun 6, 2022PAPERPATENT OWNER

Patent Owner's Notice of Deposition of Mary E. Gerritsen, Ph.D.

Jun 6, 2022PAPERPATENT OWNER

Petitioner Celltrion's Updated Exhibit List

May 31, 2022PAPERPETITIONER

Declaration of Robert V. Cerwinski ISO Motion for Pro Hac Vice Admission

May 31, 2022EXHIBITPETITIONER

Declaration of Aviv A. Zalcenstein ISO Motion for Pro Hac Vice Admission

May 31, 2022EXHIBITPETITIONER

Declaration of Brigid M. Morris ISO Motion for Pro Hac Vice Admission

May 31, 2022EXHIBITPETITIONER

Petitioner's Motion to Seal (5-27-22)

May 27, 2022PAPERPETITIONER

Ex. 1093 - Brown Dep. Ex. 12, Clark

May 27, 2022EXHIBITPETITIONER

Ex. 1094 - Dadgostar

May 27, 2022EXHIBITPETITIONER

Ex. 1095 - Gupta

May 27, 2022EXHIBITPETITIONER

Ex. 1102 - ���959 FH, 12-22-2011 PTE

May 27, 2022EXHIBITPETITIONER

Ex. 1103 - Klibanov Dep. Ex. 3, Klibanov Amgen Decl.

May 27, 2022EXHIBITPETITIONER

Ex. 1104 - Klibanov Dep. Ex. 18, Hanhart

May 27, 2022EXHIBITPETITIONER

Ex. 1105 - Klibanov Dep. Ex. 19, Stefanini

May 27, 2022EXHIBITPETITIONER

Ex. 1106 - Klibanov Dep. Ex. 20, Yang

May 27, 2022EXHIBITPETITIONER

Ex. 1107 - Klibanov Dep. Ex. 22, WHO Drug Info

May 27, 2022EXHIBITPETITIONER

Ex. 1108 - Klibanov Dep. Tr. CONFIDENTIAL

May 27, 2022EXHIBITPETITIONER

Ex. 1108 - Klibanov Tr. REDACTED

May 27, 2022EXHIBITPETITIONER

Ex. 1109 - Do Dep. Tr.

May 27, 2022EXHIBITPETITIONER

Ex. 1110 - Brown Dep. Tr.

May 27, 2022EXHIBITPETITIONER

Ex. 1111 - Del Priore Dep. Tr. CONFIDENTIAL

May 27, 2022EXHIBITPETITIONER

Ex. 1111 - Del Priore Dep. Tr. REDACTED

May 27, 2022EXHIBITPETITIONER

Ex. 1112 - Klibanov Dep. Ex. 14, Duncan

May 27, 2022EXHIBITPETITIONER

Ex. 1113 - Del Priore Dep. Ex. 10, Rudge 2008

May 27, 2022EXHIBITPETITIONER

Ex. 1114 - Albini Reply Decl. CONFIDENTIAL

May 27, 2022EXHIBITPETITIONER

Ex. 1114 - Albini Reply Decl. REDACTED

May 27, 2022EXHIBITPETITIONER

Ex. 1115 - Gerritsen Reply Decl.

May 27, 2022EXHIBITPETITIONER

Ex. 1116 - Transcript (19-May-2022)

May 27, 2022EXHIBITPETITIONER

Ex. 1117 - Klibanov Dep. Ex. 6, ���173 patent SEQ. ID No 2

May 27, 2022EXHIBITPETITIONER

Ex. 1118 - Klibanov Dep. Ex. 9, CAS

May 27, 2022EXHIBITPETITIONER

Ex. 1119 - Klibanov Dep. Ex. 12, Rudge 2007

May 27, 2022EXHIBITPETITIONER

Ex. 1120 - Klibanov Dep. Ex. 13, Gomez-Manzano

May 27, 2022EXHIBITPETITIONER

Ex. 1121 - Klibanov Dep. Ex. 21, Liu

May 27, 2022EXHIBITPETITIONER

Ex. 1122 - AA Alignment

May 27, 2022EXHIBITPETITIONER

Ex. 1123 - Quiram

May 27, 2022EXHIBITPETITIONER

Ex. 1124 - NA Alignment

May 27, 2022EXHIBITPETITIONER

Ex. 1125 - HPE 2006

May 27, 2022EXHIBITPETITIONER

Ex. 1126 - Volkin & Klibanov 1992

May 27, 2022EXHIBITPETITIONER

Ex. 1127 - 959 FH, Election re PTE

May 27, 2022EXHIBITPETITIONER

Ex. 1128 - 959 FH, PTE Certificate

May 27, 2022EXHIBITPETITIONER

Ex. 1129 - Wulff

May 27, 2022EXHIBITPETITIONER

Ex. 1130 - Do Dep. Ex. 2, Regeneron (22-Nov-2019)

May 27, 2022EXHIBITPETITIONER

Ex. 1131 - Do Dep. Ex. 3, Vanderkam

May 27, 2022EXHIBITPETITIONER

Petitioner's Reply (CONFIDENTIAL)

May 27, 2022PAPERPETITIONER

Petitioner's Reply (REDACTED)

May 27, 2022PAPERPETITIONER

Order: Other

May 11, 2022PAPERBOARD

Petitioner's Notice of Deposition of Doris Weber

May 3, 2022PAPERPETITIONER

Petitioner Unopposed Motion for Pro Hac Vice Admission of Eric R. Hunt

Apr 20, 2022PAPERPETITIONER

Declaration of Eric R. Hunt in Support of Petitioner Unopposed Motion for Pro Hac Vice Admission

Apr 20, 2022EXHIBITPETITIONER

Petitioner's Updated Power of Attorney

Apr 20, 2022PAPERPETITIONER

Petitioner's Updated Exhibit List

Apr 20, 2022PAPERPETITIONER

Petitioner's Amended Mandatory Notices

Apr 20, 2022PAPERPETITIONER

Petitioner's Notice of Deposition of Lucian V. Del Priore M.D. Ph.D.

Apr 19, 2022PAPERPETITIONER

Petitioner's Notice of Deposition of David M. Brown M.D.

Apr 15, 2022PAPERPETITIONER

Petitioner's Notice of Deposition of Diana V. Do M.D.

Apr 11, 2022PAPERPETITIONER

Order: Revised Joint Scheduling Order

Mar 23, 2022PAPERBOARD

Petitioner's Notice of Deposition of Alexander M. Klibanov Ph.D.

Mar 14, 2022PAPERPETITIONER

Patent Owner's Response to Petitioner's Identification of Statements Supported by Objected to References in Patent Owner Responses

Mar 3, 2022PAPERPATENT OWNER

PETITIONER'S IDENTIFICATION OF STATEMENTS SUPPORTED BY OBJECTED TO REFERENCES IN PATENT OWNER RESPONSES

Feb 28, 2022PAPERPETITIONER

Petitioner's Updated Exhibit List

Feb 28, 2022PAPERPETITIONER

Ex. 1089 - Transcript (23-February-2022)

Feb 28, 2022EXHIBITPETITIONER

Petitioner's Second Objections to Patent Owner's Exhibits

Feb 18, 2022PAPERPETITIONER

Patent Owner's Motion to Seal

Feb 11, 2022PAPERPATENT OWNER

Expert Declaration of Lucian V Del Priore, M.D., Ph.D (Conf.)

Feb 11, 2022EXHIBITPATENT OWNER

Expert Declaration of Lucian V Del Priore, M.D., Ph.D (Redacted)

Feb 11, 2022EXHIBITPATENT OWNER

Expert Declaration of Alexander M. Klibanov, Ph.D (Conf.)

Feb 11, 2022EXHIBITPATENT OWNER

Expert Declaration of Alexander M. Klibanov, Ph.D (Redacted)

Feb 11, 2022EXHIBITPATENT OWNER

Expert Declaration of David M. Brown, M.D.

Feb 11, 2022EXHIBITPATENT OWNER

NCT00794417

Feb 11, 2022EXHIBITPATENT OWNER

NCT01148615

Feb 11, 2022EXHIBITPATENT OWNER

Ferrara 2006

Feb 11, 2022EXHIBITPATENT OWNER

Kim 2012

Feb 11, 2022EXHIBITPATENT OWNER

Ramazi 2021

Feb 11, 2022EXHIBITPATENT OWNER

Bork 2009

Feb 11, 2022EXHIBITPATENT OWNER

Koehler-Stec Report (Conf.)

Feb 11, 2022EXHIBITPATENT OWNER

VGFT-OD-0605 Analysis Summary (Conf.)

Feb 11, 2022EXHIBITPATENT OWNER

Kim 2021

Feb 11, 2022EXHIBITPATENT OWNER

Nieto 2013

Feb 11, 2022EXHIBITPATENT OWNER

Fernandez-Ferreiro 2017

Feb 11, 2022EXHIBITPATENT OWNER

Shen 2007

Feb 11, 2022EXHIBITPATENT OWNER

Cobo 1981

Feb 11, 2022EXHIBITPATENT OWNER

Pflugfelder 1987

Feb 11, 2022EXHIBITPATENT OWNER

Hirokawa 1988

Feb 11, 2022EXHIBITPATENT OWNER

Prange 1998

Feb 11, 2022EXHIBITPATENT OWNER

Kleiger 2000

Feb 11, 2022EXHIBITPATENT OWNER

Demarest 2004

Feb 11, 2022EXHIBITPATENT OWNER

Kuhlmann 2010

Feb 11, 2022EXHIBITPATENT OWNER

Murphy 2006

Feb 11, 2022EXHIBITPATENT OWNER

Zaltrap non-comparability (Conf.)

Feb 11, 2022EXHIBITPATENT OWNER

Sola 2009

Feb 11, 2022EXHIBITPATENT OWNER

Eylea Approval Letter

Feb 11, 2022EXHIBITPATENT OWNER

Cantu 2010

Feb 11, 2022EXHIBITPATENT OWNER

Chen 2016

Feb 11, 2022EXHIBITPATENT OWNER

NCT00519285

Feb 11, 2022EXHIBITPATENT OWNER

NCT00644124

Feb 11, 2022EXHIBITPATENT OWNER

Heier Retinal Physician 2009

Feb 11, 2022EXHIBITPATENT OWNER

Del Priore CV

Feb 11, 2022EXHIBITPATENT OWNER

Klibanov CV

Feb 11, 2022EXHIBITPATENT OWNER

Brown CV

Feb 11, 2022EXHIBITPATENT OWNER

Adamis Chapter 4

Feb 11, 2022EXHIBITPATENT OWNER

Brown 2009

Feb 11, 2022EXHIBITPATENT OWNER

Regillo 2008

Feb 11, 2022EXHIBITPATENT OWNER

Abraham 2010

Feb 11, 2022EXHIBITPATENT OWNER

Barbazetto 2010

Feb 11, 2022EXHIBITPATENT OWNER

Cruz 2006

Feb 11, 2022EXHIBITPATENT OWNER

Retinal Physician Symposium

Feb 11, 2022EXHIBITPATENT OWNER

Lucentis Label 2006

Feb 11, 2022EXHIBITPATENT OWNER

Schmidt-Erfuth 2011

Feb 11, 2022EXHIBITPATENT OWNER

Margolis 2010

Feb 11, 2022EXHIBITPATENT OWNER

Brown 2011

Feb 11, 2022EXHIBITPATENT OWNER

Heier 2011

Feb 11, 2022EXHIBITPATENT OWNER

Research Agreement (Conf.)

Feb 11, 2022EXHIBITPATENT OWNER

FDA Non-Inferiority Clinical Trials

Feb 11, 2022EXHIBITPATENT OWNER

CDER Statistical Review

Feb 11, 2022EXHIBITPATENT OWNER

FDA 22 Case Studies

Feb 11, 2022EXHIBITPATENT OWNER

Heier 2005

Feb 11, 2022EXHIBITPATENT OWNER

NCT00320788

Feb 11, 2022EXHIBITPATENT OWNER

Wells 2015

Feb 11, 2022EXHIBITPATENT OWNER

Retinal Physician - Ongoing Treatment

Feb 11, 2022EXHIBITPATENT OWNER

Mathis 2009

Feb 11, 2022EXHIBITPATENT OWNER

Cousins 2010

Feb 11, 2022EXHIBITPATENT OWNER

Helzner 2007

Feb 11, 2022EXHIBITPATENT OWNER

Regeneron Press Release Nov. 18, 2011

Feb 11, 2022EXHIBITPATENT OWNER

FDA Expedited Programs

Feb 11, 2022EXHIBITPATENT OWNER

NCT01486771

Feb 11, 2022EXHIBITPATENT OWNER

Gallemore 2008

Feb 11, 2022EXHIBITPATENT OWNER

Kanghong Press Release - Chinese

Feb 11, 2022EXHIBITPATENT OWNER

Kanghong Press Release - English Translation

Feb 11, 2022EXHIBITPATENT OWNER

Thomas 2013

Feb 11, 2022EXHIBITPATENT OWNER

Ohr 2012

Feb 11, 2022EXHIBITPATENT OWNER

FDA Approves Eylea for Wet AMD

Feb 11, 2022EXHIBITPATENT OWNER

Regeneron Corrected Press Release Nov. 18, 2011

Feb 11, 2022EXHIBITPATENT OWNER

Macugen Approval Letter

Feb 11, 2022EXHIBITPATENT OWNER

Brown 2006

Feb 11, 2022EXHIBITPATENT OWNER

Rosenfeld 2006

Feb 11, 2022EXHIBITPATENT OWNER

Genentech Press Release Dec. 30, 2005

Feb 11, 2022EXHIBITPATENT OWNER

Genentech Press Release June 30, 2006

Feb 11, 2022EXHIBITPATENT OWNER

NCT00473330

Feb 11, 2022EXHIBITPATENT OWNER

NCT00473382

Feb 11, 2022EXHIBITPATENT OWNER

NCT00486018

Feb 11, 2022EXHIBITPATENT OWNER

NCT00485836

Feb 11, 2022EXHIBITPATENT OWNER

NCT00943072

Feb 11, 2022EXHIBITPATENT OWNER

NCT01012973

Feb 11, 2022EXHIBITPATENT OWNER

VGFT-OD-0605 Protocol Signature Page (Conf.)

Feb 11, 2022EXHIBITPATENT OWNER

Gerritsen Depo Transcript

Feb 11, 2022EXHIBITPATENT OWNER

Albini Depo Transcript

Feb 11, 2022EXHIBITPATENT OWNER

EXPUNGED

Feb 11, 2022PAPERPATENT OWNER

Corrected Patent Owner Response

Feb 11, 2022PAPERPATENT OWNER

Order: DECISION Granting Institution of Inter Partes Review Granting Motion for Joinder

Feb 9, 2022PAPERBOARD

Other: DECISION Granting Institution of Inter Partes Review Granting Motion for Joinder

Feb 9, 2022PAPERBOARD

EXPUNGED

Feb 7, 2022EXHIBITBOARD

Patent Owner's Unopposed Motion for Entry of Default Protective Order

Feb 3, 2022PAPERPATENT OWNER

Notice of Stipulated Schedule

Dec 9, 2021PAPERPATENT OWNER

Granting Patent Owners Unopposed Motions for Admission pro hac vice of Victoria Reines, Daniel Reisner, Matthew M. Wilk, and Jeremy Cobb 37 C.F.R. sec 42.10

Dec 9, 2021PAPERBOARD

Petitioner's Objections to Patent Owner's Exhibits

Nov 26, 2021PAPERPETITIONER

Patent Owner's Objections to Petitioner's Exhibits

Nov 24, 2021PAPERPATENT OWNER

Patent Owner's Power of Attorney

Nov 22, 2021PAPERPATENT OWNER

Patent Owner's Updated Mandatory Notices

Nov 22, 2021PAPERPATENT OWNER

Patent Owner's Updated Exhibit List

Nov 22, 2021PAPERPATENT OWNER

Pro Hac Vice Motion to Admit Victoria Reines

Nov 22, 2021PAPERPATENT OWNER

Declaration of Victoria Reines

Nov 22, 2021EXHIBITPATENT OWNER

Pro Hac Vice Motion to Admit Daniel Reisner

Nov 22, 2021PAPERPATENT OWNER

Declaration of Daniel Reisner

Nov 22, 2021EXHIBITPATENT OWNER

Pro Hac Vice Motion to Admit Matthew M. Wilk

Nov 22, 2021PAPERPATENT OWNER

Declaration of Matthew M. Wilk

Nov 22, 2021EXHIBITPATENT OWNER

Pro Hac Vice Motion to Admit Jeremy Cobb

Nov 22, 2021PAPERPATENT OWNER

Declaration of Jeremy Cobb

Nov 22, 2021EXHIBITPATENT OWNER

Order: JOINT SCHEDULING ORDER

Nov 12, 2021PAPERBOARD

Institution Decision: Grant

Nov 10, 2021PAPERBOARD

Patent Owner's Consolidated Sur-reply to Reply to Preliminary Response

Oct 6, 2021PAPERPATENT OWNER

Patent Owner's Updated Exhibit List

Oct 6, 2021PAPERPATENT OWNER

Thomson Reuters Press Release

Oct 6, 2021EXHIBITPATENT OWNER

Petitioner's Amended Mandatory Notices

Oct 1, 2021PAPERPETITIONER

Mylan Reply to POPR

Sep 29, 2021PAPERPETITIONER

Petitioner���s Updated Exhibit List

Sep 29, 2021PAPERPETITIONER

Ex.1087 - One Page Dixon IDS Disclosure

Sep 29, 2021EXHIBITPETITIONER

Ex.1088 - 597 FH Excerpts (NXP)

Sep 29, 2021EXHIBITPETITIONER

Patent Owner's Updated Mandatory Notices

Sep 24, 2021PAPERPATENT OWNER

Order: Additional Briefing

Sep 22, 2021PAPERBOARD

ORDER Authorizing Petitioners Unopposed Motion to Amend its Mandatory Notices 37 C.F.R. 42.8

Sep 22, 2021PAPERBOARD

Mylan Pharmaceuticals Inc.���s Unopposed Motion to Amend Its Mandatory Notices

Sep 14, 2021PAPERPETITIONER

Petitioners Updated Exhibit List

Sep 10, 2021PAPERPETITIONER

Ex. 1086 - Transcript (8-September-2021)

Sep 10, 2021EXHIBITPETITIONER

Lucentis (ranibzumab injection) label, revised June 2010

Aug 16, 2021EXHIBITPATENT OWNER

Tender Offer to Momenta

Aug 16, 2021EXHIBITPATENT OWNER

Press Release, Aug. 19, 2020

Aug 16, 2021EXHIBITPATENT OWNER

Press Release, Oct. 1, 2020

Aug 16, 2021EXHIBITPATENT OWNER

Press Release, Sept. 28, 2008

Aug 16, 2021EXHIBITPATENT OWNER

NCT00637337

Aug 16, 2021EXHIBITPATENT OWNER

US Patent App. Pub. 2006/0058234 A1

Aug 16, 2021EXHIBITPATENT OWNER

Excerpts from Biochemistry, 5th Ed.

Aug 16, 2021EXHIBITPATENT OWNER

Stewart & Rosenfeld 2008

Aug 16, 2021EXHIBITPATENT OWNER

Iacono 2010

Aug 16, 2021EXHIBITPATENT OWNER

Do 2009

Aug 16, 2021EXHIBITPATENT OWNER

Moroney 2009

Aug 16, 2021EXHIBITPATENT OWNER

US Patent App. Pub. 2010/0160233 A1

Aug 16, 2021EXHIBITPATENT OWNER

Hachiya 2007

Aug 16, 2021EXHIBITPATENT OWNER

Piques 2009

Aug 16, 2021EXHIBITPATENT OWNER

Jaffe 2016

Aug 16, 2021EXHIBITPATENT OWNER

Eylea (aflibercept) Injection label, revised May 2016

Aug 16, 2021EXHIBITPATENT OWNER

NCT02247531

Aug 16, 2021EXHIBITPATENT OWNER

NCT02247479

Aug 16, 2021EXHIBITPATENT OWNER

NCT03630952

Aug 16, 2021EXHIBITPATENT OWNER

NCT03577899

Aug 16, 2021EXHIBITPATENT OWNER

NCT01944839

Aug 16, 2021EXHIBITPATENT OWNER

NCT01940900

Aug 16, 2021EXHIBITPATENT OWNER

BiopharmaDive article, Aug. 14, 2017

Aug 16, 2021EXHIBITPATENT OWNER

Li 2014

Aug 16, 2021EXHIBITPATENT OWNER

Presentation, Sept. 30, 2007

Aug 16, 2021EXHIBITPATENT OWNER

Bhisitkul & Stewart 2010

Aug 16, 2021EXHIBITPATENT OWNER

Park 2012

Aug 16, 2021EXHIBITPATENT OWNER

Spaide 2007

Aug 16, 2021EXHIBITPATENT OWNER

Boyer 2009

Aug 16, 2021EXHIBITPATENT OWNER

Lucentis (ranibzumab injection) label, revised March 2018

Aug 16, 2021EXHIBITPATENT OWNER

US Patent 7,303,746

Aug 16, 2021EXHIBITPATENT OWNER

US Patent 7,521,049

Aug 16, 2021EXHIBITPATENT OWNER

US Patent 7,303,747

Aug 16, 2021EXHIBITPATENT OWNER

US Patent 7,306,799

Aug 16, 2021EXHIBITPATENT OWNER

Macugen (pegaptanib sodium injection) label

Aug 16, 2021EXHIBITPATENT OWNER

Press Release, Feb. 14, 2013

Aug 16, 2021EXHIBITPATENT OWNER

Press Release, Feb. 6, 2020

Aug 16, 2021EXHIBITPATENT OWNER

Press Release, Dec. 20, 2010

Aug 16, 2021EXHIBITPATENT OWNER

Levine 2009

Aug 16, 2021EXHIBITPATENT OWNER

Preliminary Response of Patent Owner Regeneron Pharmaceuticals, Inc.

Aug 16, 2021PAPERPATENT OWNER

DECISION Granting Petitioners Motions for Admission pro hac vice of William A. Rakoczy and Heinz J. Salmen 37 C.F.R. Sec 42.10

Jul 22, 2021PAPERBOARD

Mylan Pharmaceuticals Inc.���s Unopposed Motion For Pro Hac Vice Admission Of William A. Rakoczy

Jun 18, 2021PAPERPETITIONER

Ex.1084 - WAR Declaration (PHV Admission) - 069 petition (6-18-21)

Jun 18, 2021EXHIBITPETITIONER

Mylan Pharmaceuticals Inc.���s Unopposed Motion For Pro Hac Vice Admission Of Heinz J. Salmen

Jun 18, 2021PAPERPETITIONER

Ex.1085 - HJS Declaration (PHV Admission) - 069 petition (6-18-21)

Jun 18, 2021EXHIBITPETITIONER

Petitioner���s Exhibit List - 069 petition (6-18-21)

Jun 18, 2021PAPERPETITIONER

Patent Owner's Power of Attorney

May 24, 2021PAPERPATENT OWNER

Patent Owner's Mandatory Notices

May 24, 2021PAPERPATENT OWNER

Notice of Accord Filing Date

May 14, 2021PAPERBOARD

Ex.1001 - 069 patent

May 5, 2021EXHIBITPETITIONER

Ex.1003 - Gerritsen

May 5, 2021EXHIBITPETITIONER

Ex.1004 - Holash

May 5, 2021EXHIBITPETITIONER

Ex.1005 - Nguyen-2009

May 5, 2021EXHIBITPETITIONER

Ex.1006 - Dixon

May 5, 2021EXHIBITPETITIONER

Ex.1007 - Adis

May 5, 2021EXHIBITPETITIONER

Ex.1008 - 173 patent

May 5, 2021EXHIBITPETITIONER

Ex.1009 - 664 patent

May 5, 2021EXHIBITPETITIONER

Ex.1010 - 758 patent

May 5, 2021EXHIBITPETITIONER

Ex.1011 - Semeraro

May 5, 2021EXHIBITPETITIONER

Ex.1012 - Regeneron (28-April-2008)

May 5, 2021EXHIBITPETITIONER

Ex.1013 - Regeneron (8-May-2008)

May 5, 2021EXHIBITPETITIONER

Ex.1014 - NCT-795

May 5, 2021EXHIBITPETITIONER

Ex.1015 - NCT-377

May 5, 2021EXHIBITPETITIONER

Ex.1016 - Monthly-Dosing-Patents

May 5, 2021EXHIBITPETITIONER

Ex.1017 - 069 FH

May 5, 2021EXHIBITPETITIONER

Ex.1018 - Heier-2012

May 5, 2021EXHIBITPETITIONER

Ex.1019 - 338 patent

May 5, 2021EXHIBITPETITIONER

Ex.1020 - Heier-2009

May 5, 2021EXHIBITPETITIONER

Ex.1021 - 2009 10-Q

May 5, 2021EXHIBITPETITIONER

Ex.1022 - 757 patent

May 5, 2021EXHIBITPETITIONER

Ex.1023 - 959 patent

May 5, 2021EXHIBITPETITIONER

Ex.1024 - 758 FH - 12-22-2011 PTE

May 5, 2021EXHIBITPETITIONER

Ex.1025 - Engelbert-2010

May 5, 2021EXHIBITPETITIONER

Ex.1026 - Engelbert-2009

May 5, 2021EXHIBITPETITIONER

Ex.1027 - Spaide

May 5, 2021EXHIBITPETITIONER

Ex.1028 - Regeneron (30-April-2009)

May 5, 2021EXHIBITPETITIONER

Ex.1029 - NCT-973

May 5, 2021EXHIBITPETITIONER

Ex.1030 - Mitchell

May 5, 2021EXHIBITPETITIONER

Ex.1031 - Massin

May 5, 2021EXHIBITPETITIONER

Ex.1032 - Bayer (8-May-2008)

May 5, 2021EXHIBITPETITIONER

Ex.1033 - Dix

May 5, 2021EXHIBITPETITIONER

Ex.1034 - Fung

May 5, 2021EXHIBITPETITIONER

Ex.1035 - Lalwani

May 5, 2021EXHIBITPETITIONER

Ex.1036 - Campochiaro

May 5, 2021EXHIBITPETITIONER

Ex.1037 - Steinbrook

May 5, 2021EXHIBITPETITIONER

Ex.1038 - Albini CV

May 5, 2021EXHIBITPETITIONER

Ex.1039 - 095 patent

May 5, 2021EXHIBITPETITIONER

Ex.1040 - WHO Drug Info

May 5, 2021EXHIBITPETITIONER

Ex.1041 - Regeneron (26-February-2009)

May 5, 2021EXHIBITPETITIONER

Ex.1042 - NIH AMD

May 5, 2021EXHIBITPETITIONER

Ex.1043 - Brown

May 5, 2021EXHIBITPETITIONER

Ex.1044 - NIH DR

May 5, 2021EXHIBITPETITIONER

Ex.1045 - Ferrara-1999

May 5, 2021EXHIBITPETITIONER

Ex.1046 - Ferrara-2005

May 5, 2021EXHIBITPETITIONER

Ex.1047 - Bashshur

May 5, 2021EXHIBITPETITIONER

Ex.1048 - Lucentis

May 5, 2021EXHIBITPETITIONER

Ex.1049 - Spielberg

May 5, 2021EXHIBITPETITIONER

Ex.1050 - Schmidt-Erfuth

May 5, 2021EXHIBITPETITIONER

Ex.1051 - Keane

May 5, 2021EXHIBITPETITIONER

Ex.1052 - Rudge

May 5, 2021EXHIBITPETITIONER

Ex.1053 - Regeneron (27-March-2007)

May 5, 2021EXHIBITPETITIONER

Ex.1054 - Regeneron (2-August-2007)

May 5, 2021EXHIBITPETITIONER

Ex.1055 - Retina Society Meeting Presentation

May 5, 2021EXHIBITPETITIONER

Ex.1056 - Regeneron (28-September-2008)

May 5, 2021EXHIBITPETITIONER

Ex.1057 - Regeneron (18-February-2010)

May 5, 2021EXHIBITPETITIONER

Ex.1058 - ARVONews Winter-Spring 2008

May 5, 2021EXHIBITPETITIONER

Ex.1059 - ARVONews Summer 2007

May 5, 2021EXHIBITPETITIONER

Ex.1060 - Korobelnik

May 5, 2021EXHIBITPETITIONER

Ex.1061 - Gerritsen CV

May 5, 2021EXHIBITPETITIONER

Ex.1062 - EP-325

May 5, 2021EXHIBITPETITIONER

Ex.1064 - Wayback-BJO-Online First

May 5, 2021EXHIBITPETITIONER

Ex.1065 - BJO-Article Metrics

May 5, 2021EXHIBITPETITIONER

Ex.1066 - Bayer (18-February-2010)

May 5, 2021EXHIBITPETITIONER

Ex.1067 - Bayer (28-April-2008)

May 5, 2021EXHIBITPETITIONER

Ex.1068 - Regeneron (14-September-2009)

May 5, 2021EXHIBITPETITIONER

Ex.1069 - Background-ClinicalTrials.gov

May 5, 2021EXHIBITPETITIONER

Ex.1070 - Wayback-Affidavit (069)

May 5, 2021EXHIBITPETITIONER

Ex.1071 - Holz

May 5, 2021EXHIBITPETITIONER

Ex.1072 - Reichert

May 5, 2021EXHIBITPETITIONER

Ex.1073 - Anderson

May 5, 2021EXHIBITPETITIONER

Ex.1074 - Ciulla

May 5, 2021EXHIBITPETITIONER

Ex.1075 - Ni

May 5, 2021EXHIBITPETITIONER

Ex.1076 - Zarbin

May 5, 2021EXHIBITPETITIONER

Ex.1077 - Corporate Finance Institute

May 5, 2021EXHIBITPETITIONER

Ex.1078 - Schneider

May 5, 2021EXHIBITPETITIONER

Ex.1079 - Kuepper

May 5, 2021EXHIBITPETITIONER

Ex.1080 - Zucchi

May 5, 2021EXHIBITPETITIONER

Ex.1081 - Hayes

May 5, 2021EXHIBITPETITIONER

Ex.1082 - 069 amino acid sequences

May 5, 2021EXHIBITPETITIONER

Ex.1083 - 069 nucleotide sequences

May 5, 2021EXHIBITPETITIONER

Ex.1063 - EP-325-FH

May 5, 2021EXHIBITPETITIONER

Ex.1002 - Albini

May 5, 2021EXHIBITPETITIONER

Petition

May 5, 2021PAPERPETITIONER

Power of Attorney

May 5, 2021PAPERPETITIONER